Althea Company Pty Ltd — Althea THC18

PRA number


Published date

Product description

Althea THC18

Batch 210817

Expiry: Aug 2022

Product supplied via the TGA Special Access Scheme

Althea THC18 is medicinal cannabis that can be used in the treatment of epilepsy, nausea, chronic pain and multiple sclerosis.

Reasons the product is recalled

The level of tetrahydrocannabinol (THC) in this batch is too low and outside of the labelled concentration.

The hazards to consumers

If the level of tetrahydrocannabinol (THC) is too low, patients may receive a lower dose than prescribed and may find the product less effective, increasing the risk of serious health complications.

What consumers should do

Consumers who have been provided affected product will be contacted to arrange for the return and replacement of the product.

For more information, consumers should contact Althea Company Customer Care on 1300 702 020.

Traders who sold this product

Pharmacies in NSW and QLD

Where the product was sold

New South Wales

Dates available for sale


Responsible regulator

Therapeutic Goods Administration is the responsible regulator for this recall.

Product category

Is this page useful?